CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 57 filers reported holding CTI BIOPHARMA CORP in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,000 | +115.5% | 952,343 | +208.4% | 0.03% | +22.2% |
| Q4 2022 | $1,856 | -99.5% | 308,813 | +281.6% | 0.03% | +440.0% |
| Q1 2022 | $378,000 | -31.4% | 80,916 | -57.3% | 0.01% | -37.5% |
| Q1 2021 | $551,000 | -27.4% | 189,516 | -19.6% | 0.01% | +14.3% |
| Q4 2020 | $759,000 | – | 235,817 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,749,890 | $12,075,000 | 7.53% |
| Stonepine Capital Management, LLC | 2,054,000 | $6,614,000 | 5.06% |
| BVF INC/IL | 6,929,690 | $22,314,000 | 0.88% |
| Consonance Capital Management LP | 2,512,800 | $8,091,000 | 0.76% |
| Altium Capital Management LP | 588,992 | $1,897,000 | 0.71% |
| NEA Management Company, LLC | 7,140,450 | $22,992,000 | 0.61% |
| Ghost Tree Capital, LLC | 750,000 | $2,415,000 | 0.54% |
| Orbimed Advisors | 9,520,600 | $30,656,000 | 0.27% |
| One68 Global Capital, LLC | 39,116 | $126,000 | 0.25% |
| EAM Investors, LLC | 240,108 | $773,000 | 0.13% |